November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Comprehensive Genomic Testing Linked to Extended Survival in Advanced Lung Cancer

🧠 AI Analysis 2 min read 👁 11

Recent findings from the Journal of the National Comprehensive Cancer Network indicate that broad genomic sequencing prior to initial treatment is associated with increased survival rates in advanced non-small cell lung cancer.

Comprehensive Genomic Testing Linked to Extended Survival in Advanced Lung Cancer🧠AI Analysis

Photo: Medical Xpress

Key points

  • Broad genomic sequencing linked to longer survival in advanced lung cancer
  • Analysis of over 35,000 US patients from 2016 to 2022
  • Experts advocate for comprehensive testing before first-line treatment

A recent study published in the Journal of the National Comprehensive Cancer Network reveals that individuals diagnosed with advanced non-small cell lung cancer may experience longer overall survival when evaluated with broad-based genomic sequencing rather than limited biomarker tests. Researchers examined real-world records from over 35,000 patients treated across academic and community oncology facilities in the United States between 2016 and 2022.

The evaluation indicated that sequencing a comprehensive panel of genes prior to initiating first-line therapy was linked to an average two-month extension in overall survival, alongside slight gains in progression-free survival. Investigators noted that 19 percent of patients who underwent broad testing received precision therapies, compared to 16 percent of those given narrower assessments. This expanded testing helps clinicians pinpoint specific tumor alterations like EGFR, ALK, ROS1, and KRAS G12C to match patients with more effective treatments.

Study authors emphasize that comprehensive genomic profiling should ideally serve as the standard approach before beginning primary treatment. However, experts caution that observational real-world data can carry limitations regarding unmeasured confounding factors, and equitable access to advanced diagnostics remains an ongoing challenge across different healthcare providers and geographic regions.

What to know:

  • Broad genomic testing evaluates dozens or hundreds of genes at once to detect actionable tumor markers.
  • The retrospective study reviewed health data from more than 35,000 patients spanning 2016 to 2022.
  • Patients and families should consult their oncology care teams to verify whether comprehensive biomarker testing has been performed.

"The right test, done early, can open doors to treatments that might otherwise be missed." — Dr. Ravi B. Parikh, Emory University School of Medicine

Always talk to a qualified physician or your oncology care team for personalized medical advice and treatment decisions.

Source Medical Xpress — medicalxpress.com/news/2026-11-broad-genomic-linked-longer-survival.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.